CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Cytotoxic T lymphocytes (CTLs) suppress T cell responses directed against their antigens regardless of their own T cell receptor (TCR) specificity. This makes the use of CTLs promising for tolerance induction in autoimmunity and transplantation. It has been established that binding of the CTL CD8 molecule to the major histocompatibility complex (MHC) class I α3 domain of the recognizing T cell must be permitted for death of the latter cell to ensue. However, the signaling events triggered in the CTL by this molecular interaction in the absence of TCR recognition have never been clarified. Here we use single-cell imaging to study the events occurring in CTLs serving as targets for recognition by specific T cells. We demonstrate that CTLs actively respond to recognition by polarizing their cytotoxic granules to the contact area, releasing their lethal cargo, and vigorously proliferating. Using CTLs from perforin knockout (KO) mice and lymphocyte specific kinase (Lck) knockdown with specific small interfering RNA (siRNA), we show that the killing of the recognizing CD8 T cell is perforin dependent and is initiated by Lck signaling in the CTL. Collectively, these data suggest a novel mechanism in which the entire cascade generally triggered by TCR engagement is "hijacked" in CTLs serving as targets for T cell recognition without TCR ligation.

[1]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[2]  D. Littman,et al.  Protein kinase C-θ: signaling from the center of the T-cell synapse , 2002 .

[3]  M. Claesson,et al.  Functional Heterogeneity in Allospecific Cytotoxic T Lymphocyte Clones , 1989, Scandinavian journal of immunology.

[4]  S. Sambhara,et al.  Reduction of CTL antipeptide response mediated by CD8+ cells whose class I MHC can bind the peptide. , 1994, Journal of immunology.

[5]  S. Reich-Zeliger,et al.  Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. , 2003, Blood.

[6]  A. Velardi,et al.  Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. , 1994, Journal of immunology.

[7]  Y. Reisner,et al.  The role of veto cells in bone marrow transplantation , 2006 .

[8]  R. Germain,et al.  Variability and Robustness in T Cell Activation from Regulated Heterogeneity in Protein Levels , 2008, Science.

[9]  W. Fung-Leung,et al.  Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance. , 1995, Journal of immunology.

[10]  R. Zinkernagel,et al.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus , 1975, The Journal of experimental medicine.

[11]  S. Clouthier,et al.  Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. , 2005, Blood.

[12]  R. Rich,et al.  Inhibition of antiviral CTL responses by virus-infected cells: line item veto (cells) revisited. , 2000, Virology.

[13]  A. Sewell,et al.  Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties* , 2007, Journal of Biological Chemistry.

[14]  D. Scadden,et al.  The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  S. Kanner,et al.  CD4, CD8 and the role of CD45 in T-cell activation. , 1993, Current opinion in immunology.

[16]  G. Berke.  The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. , 1994, Annual review of immunology.

[17]  R. Rich,et al.  Characterization of the Fas Ligand/Fas-Dependent Apoptosis of Antiretroviral, Class I MHC Tetramer-Defined, CD8+ CTL by In Vivo Retrovirus-Infected Cells1 , 2002, The Journal of Immunology.

[18]  Sebastian Amigorena,et al.  In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor , 2007 .

[19]  S. Reich-Zeliger,et al.  Tolerance Induction by Veto CTLs in the TCR Transgenic 2C Mouse Model. I. Relative Reactivity of Different Veto Cells1 , 2004, The Journal of Immunology.

[20]  D A Peterson,et al.  Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Legler,et al.  CTL activation is induced by cross‐linking of TCR/MHC‐peptide‐CD8/p56lck adducts in rafts , 2001, European journal of immunology.

[22]  W. Fung-Leung,et al.  Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. , 1992, Journal of immunology.

[23]  G. Legname,et al.  Long-term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck. , 2000, Science.

[24]  J. Thomas,et al.  Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells. , 1991, Transplantation.

[25]  J. George,et al.  The molecular mechanisms of veto mediated regulation of alloresponsiveness , 1999, Journal of Molecular Medicine.

[26]  Timothy A. Springer,et al.  The dynamic regulation of integrin adhesiveness , 1994, Current Biology.

[27]  A. Tsun,et al.  The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse , 2009, Immunity.

[28]  A. Zweifach,et al.  Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing. , 2001, Immunity.

[29]  Michael L. Dustin,et al.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 , 1989, Nature.

[30]  Mark M. Davis,et al.  Shouts, whispers and the kiss of death: directional secretion in T cells , 2008, Nature Immunology.

[31]  P. Anton van der Merwe,et al.  The nature of molecular recognition by T cells , 2003, Nature Immunology.

[32]  R. Rich,et al.  Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions. , 2006, Viral immunology.

[33]  Richard G. Miller.  An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it , 1980, Nature.

[34]  M. Hahne,et al.  Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. , 1998, Blood.

[35]  John Calvin Reed,et al.  Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line , 1992, Molecular and cellular biology.

[36]  T. Ley,et al.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. , 2007, Immunity.

[37]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[38]  E. Schaeffer,et al.  PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes , 2000, Nature.

[39]  S. Reich-Zeliger,et al.  Tolerance Induction by Veto CTLs in the TCR Transgenic 2C Mouse Model. II. Deletion of Effector Cells by Fas-Fas Ligand Apoptosis1 , 2004, The Journal of Immunology.

[40]  E. Schaeffer,et al.  PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. , 2000, Nature.

[41]  H. Irie,et al.  CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity , 1995, The Journal of experimental medicine.

[42]  R. Perlmutter,et al.  Differential signaling by lymphocyte antigen receptors. , 1997, Annual review of immunology.

[43]  R. Miller,et al.  Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity , 1984, The Journal of experimental medicine.

[44]  H. Rammensee,et al.  Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. , 1984, Journal of immunology.

[45]  John Calvin Reed,et al.  Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell. , 1994 .

[46]  S. D. Gorman,et al.  Inability of CD8α′polypeptides to associate with p56 lck correlates with impaired function in vitro and lack of expression in vivo , 1989, Nature.

[47]  J. Tschopp,et al.  Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production. , 1998, Journal of immunology.

[48]  S. Reich-Zeliger,et al.  Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. , 2000, Immunity.

[49]  P. Fink,et al.  Veto cells. , 1988, Annual review of immunology.

[50]  D. Littman,et al.  Protein kinase C-theta;: signaling from the center of the T-cell synapse. , 2002, Current opinion in immunology.

[51]  E. Manos,et al.  Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. , 2000, Biochemical and biophysical research communications.

[52]  J. Thomas,et al.  A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. , 1994, Transplantation.

[53]  S. Sambhara,et al.  Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. , 1991, Science.

[54]  Michael A. Bookman,et al.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.

[55]  A. Kleinfeld,et al.  T cell receptor and CD8‐dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: activation of p56lck by CD8 binding to class I protein , 1996, European journal of immunology.

[56]  P. Henkart,et al.  Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.